Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists
OBJECTIVE: To compare the effectiveness of a third tumor necrosis factor-alpha (TNF-alpha)-blocking ...
The first approved biological agents for the treatment of rheumatoid arthritis (RA) were tumour necr...
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis ...
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versu...
To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibit...
anti-TNF agent? (TNF) agents after previous failure of an versus alternative anti-tumour necrosis fa...
Rituximab is more effective to treat rheumatoid arthritis compared to a second anti-TNFalpha blocker...
Rituximab is more effective to treat rheumatoid arthritis compared to a second anti-TNFalpha blocker...
BACKGROUND: Patients with rheumatoid arthritis (RA) with an inadequate response to TNF antagonists (...
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumato...
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to re...
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alt...
The first approved biological agents for the treatment of rheumatoid arthritis (RA) were tumour necr...
Item does not contain fulltextOBJECTIVE: To compare the effectiveness of a third tumor necrosis fact...
The first approved biological agents for the treatment of rheumatoid arthritis (RA) were tumour necr...
OBJECTIVE: To compare the effectiveness of a third tumor necrosis factor-alpha (TNF-alpha)-blocking ...
The first approved biological agents for the treatment of rheumatoid arthritis (RA) were tumour necr...
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis ...
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versu...
To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibit...
anti-TNF agent? (TNF) agents after previous failure of an versus alternative anti-tumour necrosis fa...
Rituximab is more effective to treat rheumatoid arthritis compared to a second anti-TNFalpha blocker...
Rituximab is more effective to treat rheumatoid arthritis compared to a second anti-TNFalpha blocker...
BACKGROUND: Patients with rheumatoid arthritis (RA) with an inadequate response to TNF antagonists (...
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumato...
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to re...
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alt...
The first approved biological agents for the treatment of rheumatoid arthritis (RA) were tumour necr...
Item does not contain fulltextOBJECTIVE: To compare the effectiveness of a third tumor necrosis fact...
The first approved biological agents for the treatment of rheumatoid arthritis (RA) were tumour necr...
OBJECTIVE: To compare the effectiveness of a third tumor necrosis factor-alpha (TNF-alpha)-blocking ...
The first approved biological agents for the treatment of rheumatoid arthritis (RA) were tumour necr...
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis ...
Add to ORKG